BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23088739)

  • 1. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk?
    Huygh J; Verhaegen A; Goethals K; Cosyns P; De Block C; Van Gaal L
    Crim Behav Ment Health; 2015 Jul; 25(3):226-30. PubMed ID: 25851640
    [No Abstract]   [Full Text] [Related]  

  • 3. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for those who have sexually offended or are at risk of offending.
    Khan O; Ferriter M; Huband N; Powney MJ; Dennis JA; Duggan C
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD007989. PubMed ID: 25692326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Dekker A; Briken P
    World J Biol Psychiatry; 2014 Aug; 15(6):472-8. PubMed ID: 24219802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics.
    Czerny JP; Briken P; Berner W
    Eur Psychiatry; 2002 Apr; 17(2):104-6. PubMed ID: 11973119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pharmacological treatment of paraphilias and sex offenders.
    Hill A; Briken P; Kraus C; Strohm K; Berner W
    Int J Offender Ther Comp Criminol; 2003 Aug; 47(4):407-21. PubMed ID: 12971182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatments for paraphilic patients and sexual offenders.
    Briken P; Kafka MP
    Curr Opin Psychiatry; 2007 Nov; 20(6):609-13. PubMed ID: 17921764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of paraphilias.
    Assumpção AA; Garcia FD; Garcia HD; Bradford JM; Thibaut F
    Psychiatr Clin North Am; 2014 Jun; 37(2):173-81. PubMed ID: 24877704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen deprivation treatment of sexual behavior.
    Houts FW; Taller I; Tucker DE; Berlin FS
    Adv Psychosom Med; 2011; 31():149-163. PubMed ID: 22005210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin].
    Briken P; Welzel K; Habermann N; Hill A; Berner W
    Psychiatr Prax; 2009 Jul; 36(5):232-7. PubMed ID: 19437383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].
    Briken P; Berner W; Noldus J; Nika E; Michl U
    Nervenarzt; 2000 May; 71(5):380-5. PubMed ID: 10846713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-therapy with sexual offenders].
    Stompe T
    Neuropsychiatr; 2007; 21(1):12-7. PubMed ID: 17555003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of sexual offenders in German outpatient treatment centers.
    Turner D; Gregório Hertz P; Sauter J; Briken P; Rettenberger M
    Int Clin Psychopharmacol; 2018 Nov; 33(6):349-352. PubMed ID: 29738426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses.
    Sauter J; Turner D; Briken P; Rettenberger M
    Sex Abuse; 2021 Jun; 33(4):475-500. PubMed ID: 32167420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R Scale.
    Wolba J; Tozdan S; Briken P; Freese R; Retz W; Turner D
    J Sex Med; 2023 Mar; 20(4):549-558. PubMed ID: 36861326
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.